IPOX® Global China Index (CNI)
The IPOX® Global China Index is an applied market cap-weighted index measuring the performance of the top 50 companies ranked quarterly in the IPOX® China Composite Index, subject to defined liquidity and exposure criteria. This index focuses on firms originating from the Greater China Region (including Mainland China, Hong Kong, Macau, and Taiwan) traded outside Mainland China. The IPOX® Global China Index has historically captured ca. 60% of total market cap created through New Listings by China-domiciled companies (non-A-shares) over the past four years, respectively.
Comprehensive Exposure: Captures nearly all significant IPO and spin-off activity in China (excluding A-shares) over the past four years, ensuring broad exposure to the new listings market.
Proprietary Index Technology: Utilizes IPOX®'s proven and proprietary index technology to select the 50 largest and most liquid recent IPOs and spin-offs from the IPOX® China Composite Index.
Market-Cap Weighting: Employs a market-cap weighting scheme with a 10% cap on all constituents to ensure diversified exposure across various sectors.
Quarterly Rebalancing: Rebalances on a quarterly basis to maintain focus on new listings and IPO M&A corporate actions.
The Greater China Market in Focus
China's diverse economy is reflected in the IPOX® Global China Index. The consumer sector is well-represented, featuring companies like consumer electronics leader Xiaomi, lifestyle retailer Pop Mart, online travel agent Trip.com, and travel platform Tongcheng Travel. These firms showcase China's strength in consumer technology, retail, and services.
The index also highlights China's dynamic technology and communication services sectors. Prominent holdings include e-commerce and technology giant Alibaba, online recruitment platform Kanzhun, logistics technology firm Full Truck Alliance, and telecommunications infrastructure provider China Tower. These firms underscore the technological advancement and digital transformation within Greater China.
Beyond consumer and technology, the IPOX® Global China Index includes leading companies from healthcare (such as Akeso, SKB Bio, and Giant Biogene) and industrials/transportation (like Midea Group, CRRC, and Taiwanese airline Tigerair Taiwan), reflecting the extensive range of industries participating in Greater China's capital markets.
Contact info@ipox.com to learn more about licensing and sub-advisory opportunities to provide exposure to the most promising new listings in the Chinese market.